New Research in Post-Traumatic Stress Disorder (PTSD)
Although Post-Traumatic Stress Disorder is a common diagnosis there are surprisingly few treatment options approved by the US FDA.
One new treatment pathway being explored is the N-methyl-D-aspartate receptor.This study is looking for volunteers with PTSD who are interested in assisting in the evaluation of a new medication engineered to modulate these receptors.
Signs and Symptoms of PTSD
Post-Traumatic Stress Disorder is exemplified by recurrence of disturbing and intrusive thoughts and memories surrounding the triggering event.These intrusive symptoms persist for several weeks or years after the event.
- Recurrent flashbacks of the event – often in nightmares or images the come during daytime.
- Avoidance of surroundings and activities that may trigger memories of the event.
- Depression and/or Anxiety
- Hyperarousal (being tense, easily startled)
- Primary traumatic event occurred over one year ago.
- Primary traumatic event occurred in 2001 or later
- Not using marijuana or other illicit drugs.
No Cost Study
There is no cost to participate in the study, and the study participant will receive the following:
- Medical Evaluation
- Investigational Medication.
- Study Related Medical Care.
- Compensation up to $350.
- Complimentary transportation or a travel stipend.